Davita Healthcare Partners Inc (DVA) 76.00 $DVA
DaVita Falls 1.96% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Jul 27, 3:34PM CDT
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $76.59 to a high of $78.00. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $77.40 on volume of 721,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DVA: 76.00 (-1.00)
SmarTrend Watching for Potential Rebound in Shares of DaVita After 1.96% Loss
Comtex SmarTrend(R) - Wed Jul 27, 3:33PM CDT
DaVita (NYSEVA) traded in a range yesterday that spanned from a low of $76.59 to a high of $78.00. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $77.40 on volume of 721,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DVA: 76.00 (-1.00)
Should Davita's (DVA) Stock Be in Your Portfolio Now?
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:40AM CDT
On Jul 5, 2016, we issued an updated research report on DaVita HealthCare Partners Inc. (DVA).
PMC: 26.07 (-0.35), DVA: 76.00 (-1.00), LHCG: 44.48 (-0.84), AMGN: 174.15 (-0.01)
DaVita HealthCare Partners Receives Multiple Honors from Leading Coordinated Care Association
PR Newswire - Mon Jun 20, 5:04AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), a leading independent medical group in the United States and leading global provider of kidney care services, today announced that its medical group division, HealthCare Partners, received multiple honors from CAPG, the nation's leading organization for physician groups practicing coordinated care.
DVA: 76.00 (-1.00)
DaVita Announces Intent to Enter into Transaction with Inspira Health Network to Provide Dialysis Services
PR Newswire - Wed Jun 08, 7:24AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners (NYSE: DVA), today announced its intent to enter into a joint venture acquisition with Inspira Health Network that will bring DaVita's industry-leading quality patient care to Southern New Jersey. The proposed joint venture would transfer majority ownership of three Inspira dialysis centers located in Vineland, Millville and Bridgeton to DaVita and create opportunities to grow dialysis services throughout the communities which Inspira currently serves.
DVA: 76.00 (-1.00)
DaVita Kidney Care Releases Free Kidney-Friendly Cookbook
PR Newswire - Tue May 24, 5:13AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today announced the launch of its 2016 summer cookbook, a tasty collection of grilling and picnic recipes to encourage outdoor fun with friends and family.
DVA: 76.00 (-1.00)
DaVita to Expand in Orlando with Family Health Care Buyout
Zacks Equity Research - Zacks Investment Research - Mon May 23, 3:07PM CDT
DaVita Healthcare Partners (DVA) has entered into a definitive agreement to acquire Family Health Care of Central Florida to expand its presence in Orlando metro area.
PMC: 26.07 (-0.35), AFAM: 39.56 (-0.49), DVA: 76.00 (-1.00), HLS: 41.60 (-0.45)
DaVita, Northwell Health Announce Joint Venture to Deliver Full Suite of Kidney Care Services
PR Newswire - Thu May 19, 10:41AM CDT
Northwell Health (formerly North Shore-LIJ Health System) and DaVita Kidney Care, a division of DaVita HealthCare Partners (NYSE: DVA) today announced a new joint venture to serve thousands of patients in Queens and Long Island with integrated kidney care.
DVA: 76.00 (-1.00)
DaVita Announces Agreement to Acquire a Prominent Medical Group in Orlando Area
PR Newswire - Thu May 19, 8:16AM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group in the United States and leading global provider of kidney care services, announced that it entered into a definitive agreement to acquire Family Health Care of Central Florida, a highly reputable primary care group serving the Orlando metro area for more than 30 years. The transaction is expected to close in the near future. Financial terms were not disclosed.
DVA: 76.00 (-1.00)
DaVita HealthCare Partners Certified as Freedom-Centered Workplace by WorldBlu
PR Newswire - Thu May 12, 5:13AM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced that the company has been certified as a "Freedom-Centered Workplace" by WorldBlu. This is the ninth consecutive year the company has been recognized on the list, formerly known as "most democratic" workplaces.
DVA: 76.00 (-1.00)
DaVita Appoints President for Kidney Care Business in Asia Pacific
PR Newswire - Tue May 10, 10:00AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a global provider of kidney care services, today announced that Rehan Khan will serve as president of the company's kidney care business in Asia Pacific.
DVA: 76.00 (-1.00)
Look for Shares of DaVita to Potentially Pullback after Yesterday's 3.50% Rise
Comtex SmarTrend(R) - Thu May 05, 2:09PM CDT
DaVita (NYSEVA) traded in a range yesterday that spanned from a low of $74.19 to a high of $75.95. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $74.53 on volume of 826,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DVA: 76.00 (-1.00)
DaVita Rises 3.50% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu May 05, 2:08PM CDT
DaVita (NYSEVA) traded in a range yesterday that spanned from a low of $74.19 to a high of $75.95. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $74.53 on volume of 826,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DVA: 76.00 (-1.00)
DaVita HealthCare (DVA) Q1 Earnings Beat as Revenues Rise
Zacks Equity Research - Zacks Investment Research - Thu May 05, 10:39AM CDT
DaVita HealthCare Partners Inc. (DVA) reported first-quarter 2016 adjusted operating earnings of 92 cents per share that surpassed the Zacks Consensus Estimate of 87 cents by 5.75%. Earnings increased 7% year on year.
ANTM: 125.56 (-2.05), DVA: 76.00 (-1.00), MOH: 57.02 (+0.86), HUM: 169.57 (-1.61)
DaVita, Khazanah and Mitsui to Create Joint Venture to Expand Kidney Care Services in Asia Pacific
PR Newswire - Wed May 04, 3:01PM CDT
DaVita Kidney Care, a division of DaVita (NYSE: DVA) and a leading provider of kidney care services in the United States, today announced the signing of a definitive agreement that, subject to certain closing conditions, will create a long-term joint venture. The joint venture with Khazanah Nasional Berhad, the strategic investment fund of the Government of Malaysia, and Mitsui & Co., LTD., one of the most diversified and comprehensive trading, investment and service companies in the world, is intended to support the growth of DaVita Kidney Care operations in the Asia-Pacific region.
DVA: 76.00 (-1.00)
Watch for Healthcare Stocks in Q1 Earnings: DVA, HCA, HUM
Zacks Equity Research - Zacks Investment Research - Mon May 02, 8:19AM CDT
A sneak peek into three major healthcare companies that are lined up to report earnings this week.
HCA: 75.04 (-0.48), DVA: 76.00 (-1.00), HUM: 169.57 (-1.61)
DaVita (DVA) Likely to Top Q1 Earnings: Stock to Gain?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 7:08AM CDT
We expect DaVita HealthCare Partners Inc. (DVA) to beat expectations when it reports first-quarter 2016 results on May 4, after the market closes.
ACET: 25.15 (-0.31), BDX: 176.43 (-0.35), DVA: 76.00 (-1.00), BIND: 0.78 (-0.09)
DaVita Teammates Honored for Exemplifying Core Values
PR Newswire - Wed Apr 27, 5:24AM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced that during its annual Villagewide meeting, April 13-16, the company recognized teammates for exemplifying its core values.
DVA: 76.00 (-1.00)
DaVita HealthCare Partners Inc. Schedules 2016 Capital Markets Day
PR Newswire - Tue Apr 26, 5:17PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its Capital Markets Day in New York City on Wednesday, May 18, 2016, from 8:30 a.m. to noon Eastern Time.
DVA: 76.00 (-1.00)
DaVita HealthCare Partners Inc. Schedules 1st Quarter 2016 Investor Conference Call
PR Newswire - Tue Apr 26, 5:14PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its quarterly conference call to discuss first quarter results on Wednesday, May 4, 2016, at 5:00 p.m. Eastern Time.
DVA: 76.00 (-1.00)
DaVita Falls 1.96% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Jul 27, 3:34PM CDT
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $76.59 to a high of $78.00. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $77.40 on volume of 721,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DVA: 76.00 (-1.00)
SmarTrend Watching for Potential Rebound in Shares of DaVita After 1.96% Loss
Comtex SmarTrend(R) - Wed Jul 27, 3:33PM CDT
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $76.59 to a high of $78.00. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $77.40 on volume of 721,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DVA: 76.00 (-1.00)
Should Davita's (DVA) Stock Be in Your Portfolio Now?
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:40AM CDT
On Jul 5, 2016, we issued an updated research report on DaVita HealthCare Partners Inc. (DVA).
PMC: 26.07 (-0.35), DVA: 76.00 (-1.00), LHCG: 44.48 (-0.84), AMGN: 174.15 (-0.01)
DaVita HealthCare Partners Receives Multiple Honors from Leading Coordinated Care Association
PR Newswire - Mon Jun 20, 5:04AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), a leading independent medical group in the United States and leading global provider of kidney care services, today announced that its medical group division, HealthCare Partners, received multiple honors from CAPG, the nation's leading organization for physician groups practicing coordinated care.
DVA: 76.00 (-1.00)
DaVita Announces Intent to Enter into Transaction with Inspira Health Network to Provide Dialysis Services
PR Newswire - Wed Jun 08, 7:24AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners (NYSE: DVA), today announced its intent to enter into a joint venture acquisition with Inspira Health Network that will bring DaVita's industry-leading quality patient care to Southern New Jersey. The proposed joint venture would transfer majority ownership of three Inspira dialysis centers located in Vineland, Millville and Bridgeton to DaVita and create opportunities to grow dialysis services throughout the communities which Inspira currently serves.
DVA: 76.00 (-1.00)
DaVita Kidney Care Releases Free Kidney-Friendly Cookbook
PR Newswire - Tue May 24, 5:13AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today announced the launch of its 2016 summer cookbook, a tasty collection of grilling and picnic recipes to encourage outdoor fun with friends and family.
DVA: 76.00 (-1.00)
DaVita to Expand in Orlando with Family Health Care Buyout
Zacks Equity Research - Zacks Investment Research - Mon May 23, 3:07PM CDT
DaVita Healthcare Partners (DVA) has entered into a definitive agreement to acquire Family Health Care of Central Florida to expand its presence in Orlando metro area.
PMC: 26.07 (-0.35), AFAM: 39.56 (-0.49), DVA: 76.00 (-1.00), HLS: 41.60 (-0.45)
DaVita, Northwell Health Announce Joint Venture to Deliver Full Suite of Kidney Care Services
PR Newswire - Thu May 19, 10:41AM CDT
Northwell Health (formerly North Shore-LIJ Health System) and DaVita Kidney Care, a division of DaVita HealthCare Partners (NYSE: DVA) today announced a new joint venture to serve thousands of patients in Queens and Long Island with integrated kidney care.
DVA: 76.00 (-1.00)
DaVita Announces Agreement to Acquire a Prominent Medical Group in Orlando Area
PR Newswire - Thu May 19, 8:16AM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group in the United States and leading global provider of kidney care services, announced that it entered into a definitive agreement to acquire Family Health Care of Central Florida, a highly reputable primary care group serving the Orlando metro area for more than 30 years. The transaction is expected to close in the near future. Financial terms were not disclosed.
DVA: 76.00 (-1.00)
DaVita HealthCare Partners Certified as Freedom-Centered Workplace by WorldBlu
PR Newswire - Thu May 12, 5:13AM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced that the company has been certified as a "Freedom-Centered Workplace" by WorldBlu. This is the ninth consecutive year the company has been recognized on the list, formerly known as "most democratic" workplaces.
DVA: 76.00 (-1.00)
DaVita Appoints President for Kidney Care Business in Asia Pacific
PR Newswire - Tue May 10, 10:00AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a global provider of kidney care services, today announced that Rehan Khan will serve as president of the company's kidney care business in Asia Pacific.
DVA: 76.00 (-1.00)
Look for Shares of DaVita to Potentially Pullback after Yesterday's 3.50% Rise
Comtex SmarTrend(R) - Thu May 05, 2:09PM CDT
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $74.19 to a high of $75.95. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $74.53 on volume of 826,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. DVA: 76.00 (-1.00)
DaVita Rises 3.50% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu May 05, 2:08PM CDT
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $74.19 to a high of $75.95. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $74.53 on volume of 826,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. DVA: 76.00 (-1.00)
DaVita HealthCare (DVA) Q1 Earnings Beat as Revenues Rise
Zacks Equity Research - Zacks Investment Research - Thu May 05, 10:39AM CDT
DaVita HealthCare Partners Inc. (DVA) reported first-quarter 2016 adjusted operating earnings of 92 cents per share that surpassed the Zacks Consensus Estimate of 87 cents by 5.75%. Earnings increased 7% year on year.
ANTM: 125.56 (-2.05), DVA: 76.00 (-1.00), MOH: 57.02 (+0.86), HUM: 169.57 (-1.61)
DaVita, Khazanah and Mitsui to Create Joint Venture to Expand Kidney Care Services in Asia Pacific
PR Newswire - Wed May 04, 3:01PM CDT
DaVita Kidney Care, a division of DaVita (NYSE: DVA) and a leading provider of kidney care services in the United States, today announced the signing of a definitive agreement that, subject to certain closing conditions, will create a long-term joint venture. The joint venture with Khazanah Nasional Berhad, the strategic investment fund of the Government of Malaysia, and Mitsui & Co., LTD., one of the most diversified and comprehensive trading, investment and service companies in the world, is intended to support the growth of DaVita Kidney Care operations in the Asia-Pacific region.
DVA: 76.00 (-1.00)
Watch for Healthcare Stocks in Q1 Earnings: DVA, HCA, HUM
Zacks Equity Research - Zacks Investment Research - Mon May 02, 8:19AM CDT
A sneak peek into three major healthcare companies that are lined up to report earnings this week.
HCA: 75.04 (-0.48), DVA: 76.00 (-1.00), HUM: 169.57 (-1.61)
DaVita (DVA) Likely to Top Q1 Earnings: Stock to Gain?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 7:08AM CDT
We expect DaVita HealthCare Partners Inc. (DVA) to beat expectations when it reports first-quarter 2016 results on May 4, after the market closes.
ACET: 25.15 (-0.31), BDX: 176.43 (-0.35), DVA: 76.00 (-1.00), BIND: 0.78 (-0.09)
DaVita Teammates Honored for Exemplifying Core Values
PR Newswire - Wed Apr 27, 5:24AM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced that during its annual Villagewide meeting, April 13-16, the company recognized teammates for exemplifying its core values.
DVA: 76.00 (-1.00)
DaVita HealthCare Partners Inc. Schedules 2016 Capital Markets Day
PR Newswire - Tue Apr 26, 5:17PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its Capital Markets Day in New York City on Wednesday, May 18, 2016, from 8:30 a.m. to noon Eastern Time.
DVA: 76.00 (-1.00)
DaVita HealthCare Partners Inc. Schedules 1st Quarter 2016 Investor Conference Call
PR Newswire - Tue Apr 26, 5:14PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its quarterly conference call to discuss first quarter results on Wednesday, May 4, 2016, at 5:00 p.m. Eastern Time.
DVA: 76.00 (-1.00)
